Suppr超能文献

溶瘤甲病毒 M1 生命周期在癌细胞中的可视化。

Visualization of the Oncolytic Alphavirus M1 Life Cycle in Cancer Cells.

机构信息

Department of Pharmacology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, 510080, China.

State Key Lab for Biocontrol, School of Life Sciences, Sun Yat-Sen University, Guangzhou, 510275, China.

出版信息

Virol Sin. 2021 Aug;36(4):655-666. doi: 10.1007/s12250-020-00339-7. Epub 2021 Jan 22.

Abstract

Oncolytic alphavirus M1 has been shown to selectively target and kill cancer cells, but cytopathic morphologies induced by M1 virus and the life cycle of the M1 strain in cancer cells remain unclear. Here, we study the key stages of M1 virus infection and replication in the M1 virus-sensitive HepG2 liver cancer cell line by transmission electron microscopy, specifically examining viral entry, assembly, maturation and release. We found that M1 virus induces vacuolization of cancer cells during infection and ultimately nuclear marginalization, a typical indicator of apoptosis. Specifically, our results suggest that the endoplasmic reticulum participates in the assembly of nucleocapsids. In the early and late stage of infection, three kinds of special cytopathic vacuoles are formed and appear to be involved in the replication, maturation and release of the virus. Taken together, our data displayed the process of M1 virus infection of tumor cells and provide the structural basis for the study of M1 virus-host interactions.

摘要

溶瘤性甲病毒 M1 已被证明可选择性地靶向和杀伤癌细胞,但 M1 病毒诱导的细胞病变形态和 M1 株在癌细胞中的生命周期仍不清楚。在这里,我们通过透射电子显微镜研究了 M1 病毒在 M1 病毒敏感的 HepG2 肝癌细胞系中的感染和复制的关键阶段,具体研究了病毒进入、组装、成熟和释放。我们发现 M1 病毒感染期间诱导癌细胞空泡化,最终导致核边缘化,这是凋亡的典型标志。具体而言,我们的结果表明内质网参与核衣壳的组装。在感染的早期和晚期,形成了三种特殊的细胞病变空泡,似乎参与了病毒的复制、成熟和释放。总之,我们的数据显示了 M1 病毒感染肿瘤细胞的过程,并为研究 M1 病毒-宿主相互作用提供了结构基础。

相似文献

1
Visualization of the Oncolytic Alphavirus M1 Life Cycle in Cancer Cells.
Virol Sin. 2021 Aug;36(4):655-666. doi: 10.1007/s12250-020-00339-7. Epub 2021 Jan 22.
2
Real-Time Visualization and Quantification of Oncolytic M1 Virus and .
Hum Gene Ther. 2021 Feb;32(3-4):158-165. doi: 10.1089/hum.2020.273.
3
The Identification and Development of a Novel Oncolytic Virus: Alphavirus M1.
Hum Gene Ther. 2021 Feb;32(3-4):138-149. doi: 10.1089/hum.2020.271. Epub 2021 Jan 22.
4
Identification and characterization of alphavirus M1 as a selective oncolytic virus targeting ZAP-defective human cancers.
Proc Natl Acad Sci U S A. 2014 Oct 21;111(42):E4504-12. doi: 10.1073/pnas.1408759111. Epub 2014 Oct 6.
6
Suppression of CCDC6 sensitizes tumor to oncolytic virus M1.
Neoplasia. 2021 Jan;23(1):158-168. doi: 10.1016/j.neo.2020.12.003. Epub 2020 Dec 15.
8
Intravenous injections of the oncolytic virus M1 as a novel therapy for muscle-invasive bladder cancer.
Cell Death Dis. 2018 Feb 15;9(3):274. doi: 10.1038/s41419-018-0325-3.
9
Deficiency of the IRE1α-Autophagy Axis Enhances the Antitumor Effects of the Oncolytic Virus M1.
J Virol. 2018 Feb 26;92(6). doi: 10.1128/JVI.01331-17. Print 2018 Mar 15.
10
Necroptotic virotherapy of oncolytic alphavirus M1 cooperated with Doxorubicin displays promising therapeutic efficacy in TNBC.
Oncogene. 2021 Jul;40(29):4783-4795. doi: 10.1038/s41388-021-01869-4. Epub 2021 Jun 21.

引用本文的文献

1
Nervous necrosis virus induced vacuolization is a Rab5- and actin-dependent process.
Virulence. 2024 Dec;15(1):2301244. doi: 10.1080/21505594.2023.2301244. Epub 2024 Jan 17.
2
Alphaviruses in Immunotherapy and Anticancer Therapy.
Biomedicines. 2022 Sep 13;10(9):2263. doi: 10.3390/biomedicines10092263.

本文引用的文献

1
Challenges in liver cancer and possible treatment approaches.
Biochim Biophys Acta Rev Cancer. 2020 Jan;1873(1):188314. doi: 10.1016/j.bbcan.2019.188314. Epub 2019 Nov 1.
2
Oncolytic virus immunotherapy: future prospects for oncology.
J Immunother Cancer. 2018 Dec 4;6(1):140. doi: 10.1186/s40425-018-0458-z.
4
Alphavirus Nucleocapsid Packaging and Assembly.
Viruses. 2018 Mar 20;10(3):138. doi: 10.3390/v10030138.
5
Mosquitoes as Suitable Vectors for Alphaviruses.
Viruses. 2018 Feb 14;10(2):84. doi: 10.3390/v10020084.
6
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy.
Cell. 2017 Sep 7;170(6):1109-1119.e10. doi: 10.1016/j.cell.2017.08.027.
7
Targeting VCP enhances anticancer activity of oncolytic virus M1 in hepatocellular carcinoma.
Sci Transl Med. 2017 Aug 23;9(404). doi: 10.1126/scitranslmed.aam7996.
8
Selective Antagonism of Bcl-xL Potentiates M1 Oncolysis by Enhancing Mitochondrial Apoptosis.
Hum Gene Ther. 2018 Aug;29(8):950-961. doi: 10.1089/hum.2017.055. Epub 2017 Jul 27.
9
Selective replication of oncolytic virus M1 results in a bystander killing effect that is potentiated by Smac mimetics.
Proc Natl Acad Sci U S A. 2017 Jun 27;114(26):6812-6817. doi: 10.1073/pnas.1701002114. Epub 2017 Jun 12.
10
Oncolytic Alphaviruses in Cancer Immunotherapy.
Vaccines (Basel). 2017 Apr 12;5(2):9. doi: 10.3390/vaccines5020009.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验